Compare NHC & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NHC | WGS |
|---|---|---|
| Founded | 1971 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 1997 | 2020 |
| Metric | NHC | WGS |
|---|---|---|
| Price | $189.06 | $45.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $82.00 |
| AVG Volume (30 Days) | 127.6K | ★ 1.1M |
| Earning Date | 11-06-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.42% | N/A |
| EPS Growth | 17.46 | ★ 62.37 |
| EPS | ★ 5.66 | N/A |
| Revenue | ★ $1,517,781,000.00 | $427,539,000.00 |
| Revenue This Year | N/A | $11.40 |
| Revenue Next Year | N/A | $19.61 |
| P/E Ratio | $33.38 | ★ N/A |
| Revenue Growth | 16.09 | ★ 39.97 |
| 52 Week Low | $128.00 | $32.21 |
| 52 Week High | $248.20 | $170.87 |
| Indicator | NHC | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 28.43 | 33.81 |
| Support Level | $186.65 | $32.21 |
| Resistance Level | $231.79 | $72.65 |
| Average True Range (ATR) | 6.70 | 5.39 |
| MACD | -1.64 | -0.98 |
| Stochastic Oscillator | 12.74 | 4.82 |
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.